The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are hexahydroazepinoindole and octahydroazepinoindole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).

 
Web www.patentalert.com

< Quinoline derivatives as glucokinase ligands

< N-sulfonylpiperidine cannabinoid receptor 1 antagonists

> Inhibition of atherosclerosis by diindolylmethane analogs

> Antidepressant oral liquid compositions

~ 00253